Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Marie Manley
EU Court of Justice Rules on Lundbeck Patent Settlement Agreements
On March 25, 2021, the Court of Justice of the European Union published its judgments in the Lundbeck case. The CJEU dismissed the parties’ appeals in their entirety and upheld the General Court’s findings that Lundbeck and the generic manufacturers were potential competitors and that each of the patent settlement agreements entered into by the parties restricted competition “by object.” The CJEU’s legal analysis is largely based on its judgment from January 30, 2020 in the Paroxetine case.
regulatory implications for the life sciences industry
Marie Manley and co-authors from Sidley Austin explain the updates to regulations in the EU and UK in light of the COVID-19 coronavirus pandemic. COVID-19 presents an unprecedented challenge to the global life sciences industry. UK and EU regulators have worked to provide up-to-date guidance in response to the evolving crisis and supported R&D in the hope that we will eventually be able to contain the impact of the spread.
What effect will the coronavirus have on the life sciences industry?
Marie Manley, partner at law firm Sidley Austin, looks at how UK and EU life sciences are responding to the regulatory requirements presented by Covid-19. Covid-19 presents an unprecedented challenge to the global life sciences industry. The UK and EU regulators have worked to provide up-to-date guidance in response to the evolving crisis, as well as to support research and development (R&D) that they hope will contain the impact of the spread.
The regulatory challenges of COVID-19 for life sciences
Marie Manley, partner at law firm Sidley Austin looks at how UK and EU life sciences are responding to the regulatory requirements presented by COVID-19. COVID-19 presents an unprecedented challenge to the global life sciences industry. The UK and EU regulators have worked to provide up-to-date guidance in response to the evolving crisis, as well as to support research and development (R&D) that they hope will contain the impact of the spread.
Covid-19: The implications on life sciences in the UK and EU
Marie Manley, partner at law firm Sidley Austin looks at how UK and EU life sciences are responding to the regulatory requirements presented by Covid-19. Covid-19 presents an unprecedented challenge to the global life sciences industry. The UK and EU regulators have worked to provide up-to-date guidance in response to the evolving crisis, as well as to support research and development (R&D) that they hope will contain the impact of the spread.
How software may be classified under medical device regulation guidance
Marie Manley and Zina Chatzidimitriadou discuss how software will be classified under the new European medical device regulatory framework.
To Settle or Not To Settle? An Analysis of the Servier Patent Settlement Case and it’s Practical Implications
By Marie Manley & Anne Robert Since its inquiry into the pharmaceutical sector, the European Commission (“Commission”) has been monitoring patent settlement agreements. It adopted two infringement decisions so far, each of which was appealed and led to a judgment by the General Court (“GC”). The most recent development is the GC’s judgment in the Servier case(Case T-691/14).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Marie
Contact Marie, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack